Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,566 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis.
Schuster E, Dashzeveg N, Jia Y, Golam K, Zhang T, Hoffman A, Zhang Y, Zheng C, Ramos E, Taftaf R, Shennawy LE, Scholten D, Kitata RB, Adorno-Cruz V, Reduzzi C, Spahija S, Xu R, Siziopikou KP, Platanias LC, Shah A, Gradishar WJ, Cristofanilli M, Tsai CF, Shi T, Liu H. Schuster E, et al. Among authors: shah a. bioRxiv [Preprint]. 2023 Apr 12:2023.04.10.536233. doi: 10.1101/2023.04.10.536233. bioRxiv. 2023. PMID: 37090580 Free PMC article. Preprint.
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
Jain S, Shah AN, Santa-Maria CA, Siziopikou K, Rademaker A, Helenowski I, Cristofanilli M, Gradishar WJ. Jain S, et al. Among authors: shah an. Breast Cancer Res Treat. 2018 Sep;171(2):371-381. doi: 10.1007/s10549-018-4792-0. Epub 2018 May 30. Breast Cancer Res Treat. 2018. PMID: 29850984 Clinical Trial.
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA, Zhang Q, Gerratana L, Shah AN, Zhan Y, Qiang W, Finkelman BS, Flaum L, Behdad A, Gradishar WJ, Platanias LC, Cristofanilli M. Davis AA, et al. Among authors: shah an. Breast Cancer Res. 2019 Dec 4;21(1):137. doi: 10.1186/s13058-019-1229-6. Breast Cancer Res. 2019. PMID: 31801599 Free PMC article.
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC).
Gerratana L, Zhang Q, Shah AN, Davis AA, Zhang Y, Wehbe F, Qiang W, Flaum L, Finkelman BS, Gradishar WJ, Platanias LC, Behdad A, Cristofanilli M. Gerratana L, et al. Among authors: shah an. Crit Rev Oncol Hematol. 2020 Jan;145:102856. doi: 10.1016/j.critrevonc.2019.102856. Epub 2019 Dec 23. Crit Rev Oncol Hematol. 2020. PMID: 31884205 Review.
Landscape of circulating tumour DNA in metastatic breast cancer.
Davis AA, Jacob S, Gerratana L, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar WJ, Behdad A, Cristofanilli M. Davis AA, et al. Among authors: shah an. EBioMedicine. 2020 Aug;58:102914. doi: 10.1016/j.ebiom.2020.102914. Epub 2020 Jul 21. EBioMedicine. 2020. PMID: 32707446 Free PMC article.
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.
Jacob S, Davis AA, Gerratana L, Velimirovic M, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar WJ, Behdad A, Bardia A, Cristofanilli M. Jacob S, et al. Among authors: shah an. Clin Cancer Res. 2021 Mar 1;27(5):1361-1370. doi: 10.1158/1078-0432.CCR-20-1566. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323406
12,566 results
You have reached the last available page of results. Please see the User Guide for more information.